Publications by authors named "Francesca Merchionne"

Claim this Profile
S
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica Pugliese.
Nicola Di Renzo, Emanuela Resta, Michelina Dargenio, Nicola Sgherza, Francesco Tarantini, Francesca Merchionne

Ann Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology.
Attilio Guarini, Valentina Bozzoli, Sabino Ciavarella, Michele Cimminiello, Francesca Donatelli, Francesca Merchionne

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Giuseppe Mele, Nicola Di Renzo, Nicola Cascavilla, Angelo Michele Carella, Attilio Guarini, Francesca Merchionne

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.
Carla Minoia, Nicola Sgherza, Giacomo Loseto, Giuseppina Greco, Caterina Buquicchio, Francesca Merchionne

Anticancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis.
Francesca Merchionne, Giovanni Quintana, Francesco Gaudio, Carla Minoia, Giorgina Specchia

Leuk Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target therapies in pancreatic carcinoma.
Nicola Silvestris, Antonio Gnoni, Anna Elisabetta Brunetti, Leonardo Vincenti, Daniele Santini, Francesca Merchionne

Curr Med Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugs.
Francesca Merchionne, Pasquale Iacopino, Carla Minoia, Angela Iacobazzi, Antonio Rana

Curr Med Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities of microRNAs in lymphomas.
Giacoma De Tullio, Vincenza De Fazio, Nicola Sgherza, Carla Minoia, Simona Serratì, Francesca Merchionne

Molecules· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas.
Carla Minoia, Carmela Quero, Mariaconsilia Asselti, Ida Galise, Alessia L Marzano, Francesca Merchionne

Br J Haematol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center.
Francesca Merchionne, Pasquale Procaccio, Franco Dammacco

Crit Rev Oncol Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives.
Francesca Merchionne, Franco Dammacco

Br J Haematol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival in multiple myeloma: a single-center experience.
Francesca Merchionne, Pasquale Procaccio, Franco Dammacco

Clin Exp Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapy.
Federico Perosa, Elvira Favoino, Chiara Vicenti, Francesca Merchionne, Franco Dammacco

J Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma.
Angelo Vacca, Claudio Scavelli, Guido Serini, Giulia Di Pietro, Teresa Cirulli, Francesca Merchionne

Blood· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiangiogenesis by chemotherapeutic agents.
Domenico Ribatti, Angelo Vacca, Francesca Merchionne, Marco Presta

Mini Rev Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR3-binding chemokines in multiple myeloma.
Antonio Pellegrino, Francesco Antonaci, Francesca Russo, Francesca Merchionne, Domenico Ribatti

Cancer Lett· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenesis in acute and chronic lymphocytic leukemia.
Stefano Molica, Angelo Vacca, Domenico Levato, Francesca Merchionne, Domenico Ribatti

Leuk Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cells in the bone marrow of patients with multiple myeloma.
Angelo Vacca, Roberto Ria, Fabrizio Semeraro, Francesca Merchionne, Mauro Coluccia

Blood· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
Roberto Ria, Angelo Vacca, Domenico Ribatti, Francesco Di Raimondo, Francesca Merchionne

Haematologica· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel versus paclitaxel for antiangiogenesis.
Angelo Vacca, Domenico Ribatti, Monica Iurlaro, Francesca Merchionne, Beatrice Nico

J Hematother Stem Cell Res· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis